Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 40, Issue 12 (Dec 2002)

Issues

Transthyretin Measurement as a Screening Tool for Protein Calorie Malnutrition in Emergency Hospital Admissions

Murray A. Potter / Gillian Luxton
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/CCLM.2002.233

Abstract

In this study the impact of malnutrition on hospitalized patients and the value of using transthyretin level as a screening test for malnutrition were evaluated. One hundred and forty seven consecutive patients admitted through the emergency department were included in the study. The primary outcome measures were length of stay in hospital, in-hospital mortality, and nutritional supplementation in patients with malnutrition. A cost analysis of screening with transthyretin was also performed. In 24% of the patients in the study malnutrition was diagnosed (transthyretin level < 160 mg/l), however, by determination of the albumin level (< 35 g/l) only 50% of these patients could be identified. The length of stay and mortality were 16±18 days and 17%, respectively, in patients with malnutrition, compared to 8±12 days and 4% in patients without malnutrition (p < 0.0002 and p < 0.02, respectively). Only 42% of patients with malnutrition received nutritional supplementation. Cost analysis of screening with transthyretin level projected a saving of $414 per patient screened. We conclude that malnutrition is underdiagnosed in current clinical practice and is associated with poor outcomes. Transthyretin is a biochemical marker that could be used as a cost-effective screening test to identify patients with malnutrition who may benefit from nutritional supplementation.

About the article

Published Online: 2005-06-01

Published in Print: 2002-12-10


Citation Information: Clinical Chemistry and Laboratory Medicine, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2002.233.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
HONGMEI DING, JIANHUA LIU, RONG XUE, PENG ZHAO, YI QIN, FANG ZHENG, and XUGUO SUN
Biomedical Reports, 2014, Volume 2, Number 5, Page 765
[2]
Teresa Coelho, Giampaolo Merlini, Christine E. Bulawa, James A. Fleming, Daniel P. Judge, Jeffery W. Kelly, Mathew S. Maurer, Violaine Planté-Bordeneuve, Richard Labaudinière, Rajiv Mundayat, Steve Riley, Ilise Lombardo, and Pedro Huertas
Neurology and Therapy, 2016, Volume 5, Number 1, Page 1
[3]
Peter JM Weijs, Luc Cynober, Mark DeLegge, Georg Kreymann, Jan Wernerman, and Robert R Wolfe
Critical Care, 2014, Volume 18, Number 6
[4]
Christian Aussel and Frédéric Ziegler
Revue Francophone des Laboratoires, 2014, Volume 2014, Number 465, Page 53
[5]
Sandra Marisa Oliveira, Isabel Cardoso, and Maria João Saraiva
Expert Review of Endocrinology & Metabolism, 2012, Volume 7, Number 2, Page 181
[6]
Luc Cynober and Christian Aussel
Nutrition Clinique et Métabolisme, 2004, Volume 18, Number 1, Page 49
[7]
Joel N. Buxbaum and Natàlia Reixach
Cellular and Molecular Life Sciences, 2009, Volume 66, Number 19, Page 3095

Comments (0)

Please log in or register to comment.
Log in